Utility of [18 F]FLT-PET to Assess Treatment Response in Trastuzumab-Resistant and Trastuzumab-Sensitive HER2-Overexpressing Human Breast Cancer Xenografts
Crossref DOI link: https://doi.org/10.1007/s11307-014-0770-z
Published Online: 2014-07-18
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Whisenant, Jennifer G.
McIntyre, J. Oliver
Peterson, Todd E.
Kang, Hakmook
Sánchez, Violeta
Manning, H. Charles
Arteaga, Carlos L.
Yankeelov, Thomas E.
Text and Data Mining valid from 2014-07-18